These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis. Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686 [TBL] [Abstract][Full Text] [Related]
11. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort. Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722 [TBL] [Abstract][Full Text] [Related]
12. Predicting Progression to Parkinson's Disease Dementia Using Multivariate Normative Comparisons. Agelink van Rentergem JA; de Vent NR; Huizenga HM; Murre JMJ; ; Schmand BA J Int Neuropsychol Soc; 2019 Aug; 25(7):678-687. PubMed ID: 31084642 [TBL] [Abstract][Full Text] [Related]
13. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study. Galtier I; Nieto A; Lorenzo JN; Barroso J J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723 [TBL] [Abstract][Full Text] [Related]
14. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939 [TBL] [Abstract][Full Text] [Related]
15. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a pathogenic variant in GBA for Parkinson's disease with mild cognitive impairment patients. Jiang Z; Huang Y; Zhang P; Han C; Lu Y; Mo Z; Zhang Z; Li X; Zhao S; Cai F; Huang L; Chen C; Shi Z; Zhang Y; Ling F Mol Brain; 2020 Jul; 13(1):102. PubMed ID: 32641146 [TBL] [Abstract][Full Text] [Related]
17. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia]. Toribio-Diaz ME; Carod-Artal FJ Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904 [TBL] [Abstract][Full Text] [Related]
18. Integrative Frequency Power of EEG Correlates with Progression of Mild Cognitive Impairment to Dementia in Parkinson's Disease. Gu Y; Chen J; Lu Y; Pan S Clin EEG Neurosci; 2016 Apr; 47(2):113-7. PubMed ID: 25519446 [TBL] [Abstract][Full Text] [Related]
19. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease. Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277 [TBL] [Abstract][Full Text] [Related]
20. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors. Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]